Michael A Freitas, PhD

Michael Freitas

College

College of Medicine

Department/Division

Cancer Biology and Genetics

Academic Title

Assoc Professor

Research Program

Molecular Biology and Cancer Genetics

Research Interest

Leukemia, Lymphocytic, Chronic, B-Cell, Precursor Cell Lymphoblastic Leukemia-Lymphoma

Michael Freitas, PhD, is a member of the Molecular Biology and Cancer Genetics Program at the OSUCCC – James, where he focuses his research on proteomics.

He also is involved in biomarker discovery and validation, as well as bioinformatics for mass spectrometry-based proteomics. In particular, he works to determine the side-chain modifications of proteins in chromatin remodeling and relate them to aberrant cellular function in cancer.

Among his recent research projects is a study that indicates the potential of the CD44 molecule as a prognostic biomarker in patients with multiple myeloma.

An associate professor in the Department of Cancer Biology and Genetics at Ohio State, where he also directs the Proteomics Shared Resource for the OSUCCC – James, Dr. Freitas has authored or co-authored dozens of articles in well-respected publications, such as Journal of Proteomics, Molecular & Cellular Proteomics, Journal of Proteome Research and Nucleic Acids Research.


Education and Background

Office Location

906 Biomedical Research Tower

460 W 12th Ave, Columbus, OH 43210


614-688-8432

614-292-0559



Publications

Back to Researcher Search

Please enter a keyword (i.e. Name, Research Interest) or choose a Research Program

OR

Please enter a keyword (i.e. Name, Cancer Type) or choose a Principle Investigator

OR

Search for Clinical Trials

Find a Scientific Publication